Related Experiment Video
Updated: Mar 25, 2026

Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
Published on: October 18, 2024
Respiratory Syncytial Virus Infection Triggering a Pulmonary Hypertensive Crisis in a Boy With Prader-Willi
Mari Tsukahara1, Hideaki Yagasaki1, Koichi Makino1
1Department of Pediatrics, Faculty of Medicine, University of Yamanashi, Yamanashi, JPN.
Insights
Respiratory syncytial virus (RSV) infections can cause severe respiratory and cardiac issues in children with Prader-Willi syndrome (PWS). Early screening for sleep apnea and prompt management of infections are crucial for these vulnerable patients.
Area of Science:
- Pediatrics
- Genetics
- Pulmonology
Background:
- Prader-Willi syndrome (PWS) is a genetic disorder often associated with sleep-disordered breathing.
- Respiratory infections can lead to acute decompensation in PWS patients.
- Growth hormone therapy is sometimes used in PWS management.
Abstract:
Prader-Willi syndrome (PWS) is a multisystem genetic disorder frequently complicated by sleep-disordered breathing, including obstructive sleep apnea. Respiratory infections may precipitate acute decompensation in vulnerable patients with PWS. A four-year-old boy with genetically confirmed PWS receiving growth hormone therapy developed respiratory distress and cyanosis. He was found to be respiratory syncytial virus-positive and presented with acute respiratory acidosis and markedly elevated aminotransferases with coagulopathy. Echocardiography showed right-sided cardiac dilation consistent with pulmonary hypertension. He was managed with noninvasive ventilation, oxygen supplementation, and diuretics, followed by step-down to nasal continuous positive airway pressure. Liver enzymes normalized as his respiratory status improved. Polysomnography after stabilization showed obstructive sleep apnea with considerable nocturnal desaturation, and home continuous positive airway pressure was initiated. Respiratory syncytial virus (RSV) infection can trigger acute-on-chronic respiratory failure and cardiopulmonary decompensation in children with PWS and unrecognized severe nocturnal hypoxemia. Early screening and ongoing surveillance for sleep-disordered breathing, cardiopulmonary complications, and careful management during intercurrent infections are essential. RSV immunoprophylaxis, such as palivizumab, may warrant individualized consideration in high-risk young children with PWS who have impaired airway clearance or considerable respiratory comorbidity.
More Related Videos
Related Concept Videos
Acute Respiratory Failure-IV
Acute Respiratory Failure-III
Other Pulmonary Disorders
Pulmonary Cycle: Exhalation
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:

